Press release
Aquigen Bio Expands Impurity Catalogue with the Launch of Atovaquone EP Impurity A - Now Available for Pharmaceutical Quality Control and Research
Product Page:
https://aquigenbio.com/product/atovaquone-ep-impurity-a/
What Is Atovaquone EP Impurity A?
Atovaquone EP Impurity A is a specified impurity listed in the European Pharmacopoeia (EP) for the active pharmaceutical ingredient (API) Atovaquone. As per regulatory norms, it is essential to identify, quantify, and control known and potential impurities to ensure the safety, efficacy, and quality of pharmaceutical products. Atovaquone is primarily used in the treatment and prevention of Pneumocystis jirovecii pneumonia and malaria, and its impurity profiling is critical in meeting international regulatory standards.
Aquigen Bio's Atovaquone EP Impurity A is a high-purity, well-characterized reference standard designed to help researchers and manufacturers perform accurate impurity quantification and validation studies during formulation and stability testing.
Why Pharmaceutical Companies Choose Aquigen Bio for Impurity Standards
Pharmaceutical impurity profiling is a highly sensitive and regulated domain. Aquigen Bio addresses this need by offering:
Pharmacopoeial Grade Impurities: Our Atovaquone EP Impurity A meets stringent EP guidelines and is suitable for use in method development, validation, stability studies, and routine quality checks.
High Purity & Characterization: We ensure >98% purity (confirmed via HPLC), and each batch comes with detailed characterization data, including NMR, Mass Spectrometry, and Chromatographic purity reports.
Reliable Batch Consistency: Our production process is optimized for batch-to-batch consistency, enabling long-term use and reproducibility of results in analytical laboratories.
Flexible Packaging: Available in a range of pack sizes suitable for both R&D and commercial scale operations.
Prompt Global Delivery: With an agile supply chain and a global network, we deliver to customers across Asia, Europe, and North America, ensuring timely availability even under tight project timelines.
To know more about
1.Atovaquone EP Impurity B -
https://aquigenbio.com/product/atovaquone-ep-impurity-b/
2.Atovaquone EP Impurity C -
https://aquigenbio.com/product/atovaquone-ep-impurity-c/
3.Atovaquone EP Impurity D -
https://aquigenbio.com/product/atovaquone-ep-impurity-d/
Applications of Atovaquone EP Impurity A
Impurity Profiling in Drug Development
Ensures identification and quantification of potential degradation products and related substances in Atovaquone drug substances and formulations.
Analytical Method Validation
A key component in establishing method sensitivity, specificity, and reproducibility as per ICH Q2 guidelines.
Stability Testing
Used in accelerated and long-term stability studies to monitor the formation and behavior of impurities over time.
Regulatory Submission Support
Facilitates the creation of complete impurity documentation for ANDA, NDA, and DMF submissions in regulated markets.
Contact:
Aquigen Bio Sciences
281/1, Plot No 41,
Hinjawadi - Pirangut Rd,
Kasar Amboli, Pirangut,
Pune, Maharashtra 412108
Phone: +91 7030123794
Email: bd@aquigenbio.com
Visit: www.aquigenbio.com
About Aquigen Bio Sciences
Aquigen Bio Sciences is the leading resource in India for Venetoclax Impurity Standards. Recognized for its unparalleled expertise in reference materials and pharmaceutical impurities, Aquigen supports researchers and manufacturers in overcoming critical challenges in impurity identification and quantification. With a steadfast commitment to scientific precision and quality, Aquigen Bio Sciences aids cutting-edge pharmaceutical innovation that ensures safer therapeutics for global healthcare.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Aquigen Bio Expands Impurity Catalogue with the Launch of Atovaquone EP Impurity A - Now Available for Pharmaceutical Quality Control and Research here
News-ID: 3998598 • Views: …
More Releases from Aquigen Bio Sciences
High-Purity N-Nitroso Betahistine D3 for Precise Pharmaceutical Analysis | Deute …
Product Overview
N-Nitroso Betahistine D3 is a premium deuterated nitrosamine impurity standard, specifically developed for precise analytical testing in pharmaceutical laboratories. This reference standard is widely used for analytical method development, validation, and quality control processes to meet stringent regulatory guidelines. With exceptional purity, complete documentation, and reliable traceability, it is ideal for research, development, and compliance applications.
https://aquigenbio.com/product/n-nitroso-betahistine-d3/
Key Features and Benefits
Deuterated Design for Precision: The incorporation of deuterium improves mass spectrometric…
Aquigen Bio Strengthens Pharmaceutical Research with High-Purity Icatibant Impur …
Aquigen Bio, a trusted supplier of pharmaceutical reference standards, today announced the expansion of its Icatibant Impurity Standards portfolio, designed to support drug developers, analytical laboratories, and research organizations with reliable materials for impurity profiling and quality control.
Icatibant, a selective bradykinin B2 receptor antagonist, is widely used in the treatment of hereditary angioedema (HAE). Given its peptide-based structure, Icatibant is prone to the formation of impurities during synthesis and storage.…
Elevating Analytical Precision with Harmine Impurity Standards
In the realm of pharmaceutical research, controlling the purity of compounds is pivotal. When evaluating psychoactive alkaloids such as harmine-a β-carboline alkaloid known for its reversible monoamine oxidase A inhibition and emerging therapeutic potential-accuracy is non-negotiable. This is where Aquigen Bio Sciences brings its edge: supplying high-grade impurity standards to underpin analytical consistency and regulatory compliance.
Why Harmine Impurity Standards Matter
https://aquigenbio.com/products/impurity-standards/harmine/
Harmine occurs naturally in Peganum harmala and Banisteriopsis caapi, and has…
AquigenBio Introduces High-Purity Daridorexant Hydrochloride to Support Sleep Di …
India - August 2025 - AquigenBio, a premier provider of pharmaceutical reference standards and impurity profiling solutions, proudly announces the release of Daridorexant Hydrochloride (CAS No. 1792993-84-0). This high-quality, precisely characterized compound is a hydrochloride salt form of Daridorexant, a dual orexin receptor antagonist with proven efficacy in the treatment of insomnia.
Explore Daridorexant Hydrochloride -
https://aquigenbio.com/product/daridorexant-hydrochloride/
The launch of this product marks a significant addition to AquigenBio's growing portfolio of sleep…
More Releases for Impurity
Tizanidine Nitroso Impurity 1 - High-Purity Reference Standard for Reliable Impu …
In the highly regulated world of pharmaceutical manufacturing, impurity profiling plays a critical role in ensuring drug safety, efficacy, and regulatory compliance. Among the wide range of impurity reference standards required during API development and validation, Tizanidine Nitroso Impurity 1 stands out as a vital compound for researchers and manufacturers working on Tizanidine-based formulations.
At Aquigen Bio, we are proud to offer Tizanidine Nitroso Impurity 1, a high-purity reference standard meticulously…
AquigenBio Launches High-Purity EP Impurity Standards for Propylthiouracil, Incl …
AquigenBio is pleased to announce the availability of two essential impurity reference standards-Propylthiouracil EP Impurity A and Propylthiouracil EP Impurity B. These impurity standards are now available to support pharmaceutical companies, contract research organizations, and analytical laboratories engaged in drug development, quality control, and regulatory compliance.
Propylthiouracil (PTU) is a well-known antithyroid medication, widely used in the treatment of hyperthyroidism. In line with pharmacopeial guidelines, it is critical to identify and…
Precision in Impurity Profiling: Aquigen Bio Introduces High-Purity Doxorubicin …
Pune, India - July 2025 - As regulatory standards tighten across the pharmaceutical industry, the need for accurate, high-purity reference standards has never been more critical. Aquigen Bio, a trusted provider of pharmaceutical reference materials, is proud to announce the availability of Doxorubicin Dimer Impurity 3, a key impurity used in the impurity profiling of the widely used chemotherapeutic agent, Doxorubicin.
This launch is part of Aquigen Bio's expanded portfolio of…
Breaking Ground in Pharmaceutical Impurity Standards: Aquigen Bio Expands Abirat …
In the evolving landscape of pharmaceutical development and quality control, the identification, synthesis, and supply of high-purity impurity standards play a pivotal role. One of the most significant advancements in recent times is the availability of specialized Abiraterone-related impurity standards-essential tools for characterizing drug formulations and ensuring regulatory compliance.
Manufactured and supplied by Aquigen BioSciences, a trusted leader in impurity synthesis and reference standards, these impurity standards offer analytical laboratories and…
Unlock Advanced Dabigatran Research with High-Purity Standards: Now Available - …
In the ever-evolving pharmaceutical landscape, precision, safety, and regulatory compliance have never been more crucial. With Dabigatran etexilate mesylate becoming a cornerstone in the management of thromboembolic disorders, the demand for high-purity standards and robust impurity profiling has surged. Recognizing this essential need, a new suite of advanced analytical tools for Dabigatran and its associated impurities has been made available to support the global scientific and quality control community.
To kno…
Aquigen Bio Expands Oncology Impurity Standards Portfolio with High-Purity Etopo …
India - 07/05/2025 - Aquigen Bio, a leading provider of pharmaceutical impurity reference standards, proudly announces the launch of its latest high-quality product: Etoposide EP Impurity A. This new addition to Aquigen's growing portfolio of oncology-related impurities is tailored to meet the stringent requirements of pharmaceutical manufacturers and analytical laboratories focused on drug safety, efficacy, and compliance.
To know more about : Etoposide EP Impurity A
https://aquigenbio.com/product/etoposide-ep-impurity-a/
A Strategic Addition to Oncology Drug…
